CJC-1295 (Without DAC) – 5 mL + IPA 5 mL
CJC-1295 (Without DAC) is a synthetic peptide analog of growth hormone–releasing hormone (GHRH), developed for research into endocrine signaling and growth hormone regulation. Unlike the DAC-modified version, this form is designed to reflect a shorter activity profile that more closely resembles natural GHRH behavior in biological systems.
In research environments, CJC-1295 (Without DAC) is studied for its selective interaction with GHRH receptors located in the pituitary axis. These receptors regulate pulsatile growth hormone signaling, making the peptide valuable for examining natural hormone rhythm and feedback mechanisms.
One of the defining characteristics of CJC-1295 without DAC is its rapid clearance compared to long-acting analogs. This allows researchers to investigate acute signaling responses and short-term endocrine dynamics rather than sustained hormonal elevation.
CJC-1295 (Without DAC) is frequently included in studies focused on growth hormone pulse timing and amplitude. Understanding how brief receptor activation influences downstream signaling is a key area of interest in endocrine research.
The peptide is also examined in metabolic signaling research. Growth hormone pathways are closely tied to lipid utilization, protein metabolism, and energy balance, making CJC-1295 relevant for controlled metabolic studies.
Unlike direct growth hormone analogs, CJC-1295 works by stimulating endogenous signaling pathways rather than replacing the hormone itself. This distinction allows researchers to study physiological regulation while maintaining natural feedback loops.
Researchers often use the non-DAC form to compare signaling differences between short-acting and long-acting GHRH analogs. These comparisons help clarify how peptide structure influences duration and intensity of receptor activation.
CJC-1295 (Without DAC) is also studied in gene expression research, where growth hormone–related transcriptional changes are examined following transient signaling events.
The inclusion of IPA (Isopropyl Alcohol) in research kits supports laboratory handling and preparation protocols under controlled conditions. Its presence is intended strictly for research and laboratory use.
The peptide’s predictable molecular behavior supports reproducibility in experimental settings. Consistent receptor interaction allows for reliable comparison across studies.
CJC-1295 (Without DAC) is commonly included in endocrine research that prioritizes physiological accuracy over prolonged stimulation. This makes it useful for studies focused on natural hormonal signaling patterns.
Because growth hormone signaling affects multiple tissues, the peptide is often used in systems-based research rather than isolated pathway analysis.
Its well-characterized structure and short-acting profile make CJC-1295 (Without DAC) a valuable reference compound in growth hormone research.
As interest in peptide-based endocrine investigation continues to expand, CJC-1295 (Without DAC) remains an important tool for studying regulated growth hormone signaling within complex biological systems.
New
CJC-1295 without DAC 5ml + IPA 5ml
$90.00
CJC-1295 (Without DAC) is a synthetic peptide analog of growth hormone–releasing hormone (GHRH), developed for research into endocrine signaling and growth hormone regulation. Unlike the DAC-modified version, this form is designed to reflect a shorter activity profile that more closely resembles natural GHRH behavior in biological systems.
Description
Shipping & Delivery
Related products
Dihexa (5mg x 60 Capsules = 300mg)
Dihexa is a small peptide-derived compound designed to support cognitive function and brain regeneration. It acts by activating the HGF/c-Met signaling pathway, which plays a critical role in forming new synaptic connections and enhancing neuroplasticity. Dihexa also mimics the action of brain-derived neurotrophic factor (BDNF), a key molecule involved in learning, memory, and neuronal survival. Preclinical research studies have shown that Dihexa can significantly improve memory consolidation and reverse cognitive deficits in models of Alzheimer’s disease, traumatic brain injury, and stroke. Unlike traditional nootropics or growth factors with poor blood–brain barrier penetration, Dihexa is orally bioavailable and metabolically stable, allowing for targeted CNS effects. Its unique mechanism positions it as a promising research compound for neurodegenerative conditions, offering potential in synaptic repair, inflammation reduction, and long-term cognitive enhancement. 
Epitalon 3mg (60 capsules) (Telomere Length)
Epithalon (Epitalon) has long been understood to help preserve telomeres, which are the protective end caps found on fragments of DNA (chromosomes). Telomeres protect DNA from degradation as it is replicated during cell division (one cell splitting into two). Telomeres themselves suffer degradation, however, and eventually become too short to be effective. At this point, a cell will either commit cell suicide in a process called apoptosis or it will go dormant in a process called senescence. Both processes lead to aging and eventual dysfunction and disease. Senescence is one of the primary drivers of disease and aging.
Epitalon has been shown to activate an enzyme called telomerase, which protects and repairs telomeres. More active telomerase means that cells age slower and remain functional longer. The net result is that overall aging appears to be slowed down. Research in rodents indicates that Epitalon may extend life by as much as 27% via this mechanism[2], [3].
Epitalon does not only activate telomerase. As noted above, Epitalon has been shown to affect expression for several genes through alteration of DNA structure. This process, called epigenetic modification, is of interest to scientists because it provides the foundation for controlling gene expression at a very fine level. Research is being conducted to learn how to harness epigenetic technology, which could potentially allow scientists to alter everything from an individual’s eye color to how intelligent a person is or how long someone lives.
Micro-encapsulated Epitalon has shown excellent orally bioavailability in lab research studies. 
GHK-Cu 50mg Copper Peptide
GHK-Cu is a small, naturally occurring peptide with the ability to attenuate inflammation, improve antioxidant responses, and improve gene expression on a large scale. Research shows that this copper-chelating peptide may be of critical importance both in the prevention of neurodegenerative disease and as a tool for exploring pathophysiological mechanisms. Studies in mice have revealed that GHK-Cu can protect against neurological insults, improve wound healing, reduce rates of infection, and boost blood vessel growth. The peptide has been of interest in recent years for its anti-oxidant properties that, in combination with its ability to alter gene expression patterns, appear to help slow or even reverse some aspects of aging.
Semaglutide 10
Semaglutide is a widely researched peptide-based compound recognized for its significant role in metabolic regulation and appetite control. It belongs to the class of GLP-1 receptor agonists, which are designed to mimic naturally occurring hormones involved in glucose metabolism and satiety signaling.
TB-500 (Thymosin Beta-4) (43aa) (2mg x 10 Vials = 20mg)
TB-500 (Thymosin Beta-4) is a 43 amino acid peptide sequence. In animal models, Thymosin Beta-4 has been shown to improve blood vessel growth, regulate wound healing, decrease inflammation, and reduce oxidative damage in the heart and central nervous system. Thymosin-beta-4 has a role in protection, tissue repair, regeneration and remodeling of injured or damaged tissues. It is also of active interest in anti-aging research.
Reviews
There are no reviews yet.